SHELTER
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Shelter Pharma Secures Order From Berlin International
March 21 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - SECURES ORDER FROM BERLIN INTERNATIONAL
SHELTER PHARMA - ORDER FOR 6000 OF BETA GLUCAN FORTE SYRUP 100ML
Source text: ID:nBSE6WK07c
Further company coverage: SHEH.BO
(([email protected];))
March 21 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - SECURES ORDER FROM BERLIN INTERNATIONAL
SHELTER PHARMA - ORDER FOR 6000 OF BETA GLUCAN FORTE SYRUP 100ML
Source text: ID:nBSE6WK07c
Further company coverage: SHEH.BO
(([email protected];))
Shelter Pharma To Raise Up To 500 Million Rupees Via Rights Issue
Jan 8 (Reuters) - Shelter Pharma Ltd SHEH.BO:
TO RAISE UP TO 500 MILLION RUPEES VIA RIGHTS ISSUE
Source text: ID:nBSE22dnM1
Further company coverage: SHEH.BO
(([email protected];))
Jan 8 (Reuters) - Shelter Pharma Ltd SHEH.BO:
TO RAISE UP TO 500 MILLION RUPEES VIA RIGHTS ISSUE
Source text: ID:nBSE22dnM1
Further company coverage: SHEH.BO
(([email protected];))
Shelter Pharma To Consider Fund Raising Via Rights Issue Of Shares
Jan 3 (Reuters) - Shelter Pharma Ltd SHEH.BO:
TO CONSIDER FUND RAISING VIA RIGHTS ISSUE OF SHARES
Source text: ID:nBSE61DFyL
Further company coverage: SHEH.BO
(([email protected];;))
Jan 3 (Reuters) - Shelter Pharma Ltd SHEH.BO:
TO CONSIDER FUND RAISING VIA RIGHTS ISSUE OF SHARES
Source text: ID:nBSE61DFyL
Further company coverage: SHEH.BO
(([email protected];;))
Shelter Pharma Gets Order Worth $80,000
Oct 23 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - GETS ORDER WORTH $80,000
Source text for Eikon: ID:nBSE97v8v3
Further company coverage: SHEH.BO
(([email protected];;))
Oct 23 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - GETS ORDER WORTH $80,000
Source text for Eikon: ID:nBSE97v8v3
Further company coverage: SHEH.BO
(([email protected];;))
Shelter Pharma Gets Order Worth $17,700
Sept 18 (Reuters) - Shelter Pharma Ltd SHEH.BO:
GETS ORDER WORTH $17,700
Source text for Eikon: ID:nBSE2rwjfr
Further company coverage: SHEH.BO
(([email protected];;))
Sept 18 (Reuters) - Shelter Pharma Ltd SHEH.BO:
GETS ORDER WORTH $17,700
Source text for Eikon: ID:nBSE2rwjfr
Further company coverage: SHEH.BO
(([email protected];;))
Shelter Pharma Says Secured Order From Berlin International Medical Co
June 6 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - SECURED ORDER FROM BERLIN INTERNATIONAL MEDICAL CO
SHELTER PHARMA LTD - TOTAL ORDER WORTH $120,000
Source text for Eikon: ID:nBSEcdST8K
Further company coverage: SHEH.BO
(([email protected];))
June 6 (Reuters) - Shelter Pharma Ltd SHEH.BO:
SHELTER PHARMA LTD - SECURED ORDER FROM BERLIN INTERNATIONAL MEDICAL CO
SHELTER PHARMA LTD - TOTAL ORDER WORTH $120,000
Source text for Eikon: ID:nBSEcdST8K
Further company coverage: SHEH.BO
(([email protected];))
Shelter Pharma Gets Order Worth 10 Million Rupees
Nov 29 (Reuters) - Shelter Pharma Ltd SHEH.BO:
GETS ORDER WORTH 10 MILLION RUPEES
Source text for Eikon: ID:nBSE3T2Vz8
Further company coverage: SHEH.BO
(([email protected];))
Nov 29 (Reuters) - Shelter Pharma Ltd SHEH.BO:
GETS ORDER WORTH 10 MILLION RUPEES
Source text for Eikon: ID:nBSE3T2Vz8
Further company coverage: SHEH.BO
(([email protected];))
Shelter Pharma Received Official Approvals To Export For Premium Range Of Nutraceutical Products To Kuwait Market
Sept 21 (Reuters) - Shelter Pharma Ltd SHEH.BO:
RECEIVED OFFICIAL APPROVALS TO EXPORT FOR PREMIUM RANGE OF NUTRACEUTICAL PRODUCTS TO KUWAIT MARKET
Source text for Eikon: ID:nBSEb3RRMy
Further company coverage: SHEH.BO
(([email protected];;))
Sept 21 (Reuters) - Shelter Pharma Ltd SHEH.BO:
RECEIVED OFFICIAL APPROVALS TO EXPORT FOR PREMIUM RANGE OF NUTRACEUTICAL PRODUCTS TO KUWAIT MARKET
Source text for Eikon: ID:nBSEb3RRMy
Further company coverage: SHEH.BO
(([email protected];;))
Events:
Dividend
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Shelter Pharma do?
Shelter Pharma Limited specializes in manufacturing herbal products for Human Pharma and Veterinary segments in Gujarat. They offer a range of OTC and Ethical pharma products developed through in-house R&D and Ayurvedic expertise.
Who are the competitors of Shelter Pharma?
Shelter Pharma major competitors are Bandaram Pharma Pack, Walpar Nutritions, Medicamen Organics, Roopa Industries, Chandra Bhagat Pharm, Shanmuga Hospital, Deccan Health Care. Market Cap of Shelter Pharma is ₹46 Crs. While the median market cap of its peers are ₹49 Crs.
Is Shelter Pharma financially stable compared to its competitors?
Shelter Pharma seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Shelter Pharma pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Shelter Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Shelter Pharma allocated its funds?
NA
How strong is Shelter Pharma balance sheet?
Balance sheet of Shelter Pharma is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Shelter Pharma improving?
Yes, profit is increasing. The profit of Shelter Pharma is ₹7.24 Crs for TTM, ₹6.2 Crs for Mar 2024 and ₹5.21 Crs for Mar 2023.
Is the debt of Shelter Pharma increasing or decreasing?
Yes, The net debt of Shelter Pharma is increasing. Latest net debt of Shelter Pharma is -₹2.38 Crs as of Mar-25. This is greater than Mar-24 when it was -₹8.65 Crs.
Is Shelter Pharma stock expensive?
Shelter Pharma is not expensive. Latest PE of Shelter Pharma is 6.39, while 3 year average PE is 9.9. Also latest EV/EBITDA of Shelter Pharma is 0 while 3yr average is 4.34.
Has the share price of Shelter Pharma grown faster than its competition?
Shelter Pharma has given lower returns compared to its competitors. Shelter Pharma has grown at ~-24.14% over the last 1yrs while peers have grown at a median rate of -7.45%
Is the promoter bullish about Shelter Pharma?
Promoters seem not to be bullish about the company and have been selling shares in the open market. Latest quarter promoter holding in Shelter Pharma is 52.32% and last quarter promoter holding is 54.97%
Are mutual funds buying/selling Shelter Pharma?
There is Insufficient data to gauge this.